Rossari Biotech Limited

NSEI:ROSSARI Stock Report

Market Cap: ₹41.4b

Rossari Biotech Management

Management criteria checks 4/4

Rossari Biotech's CEO is Sunil Chari, appointed in Jan 2003, has a tenure of 21.33 years. total yearly compensation is ₹11.13M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 30.93% of the company’s shares, worth ₹12.80B. The average tenure of the management team and the board of directors is 2.7 years and 4.5 years respectively.

Key information

Sunil Chari

Chief executive officer

₹11.1m

Total compensation

CEO salary percentage100.0%
CEO tenure21.3yrs
CEO ownership30.9%
Management average tenure2.7yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

CEO Compensation Analysis

How has Sunil Chari's remuneration changed compared to Rossari Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹11m₹11m

₹1b

Dec 31 2022n/an/a

₹1b

Sep 30 2022n/an/a

₹995m

Jun 30 2022n/an/a

₹1b

Mar 31 2022₹10m₹10m

₹977m

Dec 31 2021n/an/a

₹957m

Sep 30 2021n/an/a

₹948m

Jun 30 2021n/an/a

₹892m

Mar 31 2021₹9m₹9m

₹802m

Dec 31 2020n/an/a

₹729m

Sep 30 2020n/an/a

₹695m

Jun 30 2020n/an/a

₹666m

Mar 31 2020₹8m₹7m

₹653m

Mar 31 2019₹5mn/a

₹457m

Mar 31 2018₹9mn/a

₹254m

Compensation vs Market: Sunil's total compensation ($USD133.34K) is below average for companies of similar size in the Indian market ($USD271.33K).

Compensation vs Earnings: Sunil's compensation has been consistent with company performance over the past year.

CEO

Sunil Chari (58 yo)

21.3yrs

Tenure

₹11,130,000

Compensation

Mr. Sunil Srinivasan Chari serves as a Managing Director of Rossari Biotech Limited since September 26, 2019 and serves as its Director since 2009. He is a co-founder of Rossari Biotech Limited in 2003. He...

Leadership Team

NamePositionTenureCompensationOwnership
Edward Menezes
Co-Founder & Executive Chairman15.3yrs₹11.12m30.99%
₹ 12.8b
Sunil Chari
Co-Founder21.3yrs₹11.13m30.93%
₹ 12.8b
Ketan Sablok
Chief Financial Officerless than a yearno datano data
Mikhail Menezes
Director of Technicalno datano data0.24%
₹ 99.8m
Shifa Suresh
Vice President of Human Resources & Administration2.7yrsno datano data
Parul Gupta
Company Secretary & Compliance Officer4.5yrs₹1.00mno data
Yash Chari
Director of Marketing & Business Developmentno datano data0.30%
₹ 123.6m
Sunil V
Chief Human Resource Officerless than a yearno datano data
Puneet Arora
Chief Executive Officer of Textile Chemicals Globalno datano datano data
Manasi Nisal
Senior Vice President of Strategy & Business Analyticsless than a year₹4.00mno data
Prasad Gadkari
President of Manufacturingno datano datano data

2.7yrs

Average Tenure

48.5yo

Average Age

Experienced Management: ROSSARI's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Edward Menezes
Co-Founder & Executive Chairman15.3yrs₹11.12m30.99%
₹ 12.8b
Sunil Chari
Co-Founder15.3yrs₹11.13m30.93%
₹ 12.8b
Aseem Dhru
Independent Director4.5yrs₹2.13m0.00018%
₹ 74.5k
Annoottam Ghosh
Member of Advisory Boardno datano datano data
Vikram Gupta
Member of Advisory Boardno datano datano data
Goutam Bhattacharya
Independent Director5.4yrs₹2.58mno data
Sharabh Pachory
Independent Director4.5yrs₹1.73mno data
Jean Marcopoulos
Member of Advisory Boardno datano datano data
Klaus Karl
Member of Advisory Boardno datano datano data
Aparna Sharma
Non-Executive Independent Directorless than a yearno datano data
Esha Achan
Additional Non-Executive Independent Directorless than a yearno datano data

4.5yrs

Average Tenure

60.5yo

Average Age

Experienced Board: ROSSARI's board of directors are considered experienced (4.5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.